Eleonore Crespo, co-CEO of Pigment, expressed surprise at the recent US export controls on certain Anthropic AI models, stating that this change signals a shift towards model-agnostic strategies being “the new normal.” These controls led to Anthropic suspending access to its most advanced AI models globally, a move that has raised concerns among European officials about potential discrimination in access to advanced technologies. The industry is increasingly adapting to these regulatory challenges by embracing model-agnostic approaches.

Pigment: Pigment is a business planning and AI-powered performance management platform that integrates data from finance, sales, HR, and supply chain functions to support organizational decision-making. Co-CEO Eleonore Crespo recently addressed the impact of US export controls on advanced AI models in a public interview. The company positions itself to maintain flexibility across AI providers amid evolving regulations.
Tom Mackenzie: Tom Mackenzie is a Bloomberg journalist and co-anchor of the daily market program Opening Trade, with a focus on technology, business, and European markets. He interviewed Pigment co-CEO Eleonore Crespo about AI model restrictions and industry adaptation strategies.
Eleonore Crespo: Eleonore Crespo is the co-founder and co-CEO of Pigment, where she oversees business strategy for its AI-driven planning platform. She has discussed AI adoption and regulatory challenges in recent interviews, including at London Tech Week 2026. In the reported exchange, she described export controls on certain Anthropic models as a shock and advocated for model-agnostic approaches as the emerging standard.

`json
{
“Regulation”: “Export controls have prompted Anthropic to reconsider access to some of its AI models for international users.”,
“Geopolitics”: “Concerns have been voiced about US AI export measures potentially impacting access to advanced models for different regions.”,
“Industry Trend”: “Companies are increasingly adopting model-agnostic AI strategies to reduce risks from regulatory limitations on certain providers.”
}
`